Internalization of radiolabelled [DTPA: Peptides for somatostatin receptor-targeted scintigraphy and radionuclide therapy0: Peptides for somatostatin receptor-targeted scintigraphy and radionuclide therapy]octreotide and [DOTA: Peptides for somatostatin receptor-targeted scintigraphy and radionuclide therapy0: Peptides for somatostatin receptor-targeted scintigraphy and radionuclide therapy, Tyr: Peptides for somatostatin receptor-targeted scintigraphy and radionuclide therapy3: Peptides for somatostatin receptor-targeted scintigraphy and radionuclide therapy]octreotide: Peptides for somatostatin receptor-targeted scintigraphy and radionuclide therapy

    loading  Checking for direct PDF access through Ovid

Abstract

Summary

We compared the internalization of [90Y-DOTA0,Tyr3]octreotide and [111In-DOTA0,Tyr3]octreotide with that of [125I-Tyr3]octreotide and [111In-DTPA0]octreotide in the subtype 2 somatostatin receptor (sst2)-positive rat pancreatic tumour cell lines Ca20948 and AR42) and in the somatostatin receptor-negative human anaplastic thyroid tumour cell line ARO. We demonstrated that [111In-DTPA0]octreotide, [90Y-DOTA0,Tyr3]octreotide and [111In-DOTA0,Tyr3]octreotide are internalized by a receptor-specific, time- and temperature-dependent process. The amount of [90Y-DOTA0,Tyr3]octreotide internalized was higher than that of [111In-DOTA0,Tyr3]octreotide and [111In-DTPA0]octreotide.

Related Topics

    loading  Loading Related Articles